Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia — and one of the strongest risk factors for stroke. Patients with AF have a 5-fold higher stroke risk than people without it. The CHA₂DS₂-VASc score quantifies that risk and guides therapy.
This article explains the score by Lip et al. (2010) and the 2020 ESC guideline, the meaning of each component, and when oral anticoagulation is indicated.
What is the CHA₂DS₂-VASc score?
The CHA₂DS₂-VASc score was introduced in 2010 by Gregory Lip et al. as an extension of the older CHADS₂ score. It identifies "low-risk" patients who would otherwise still suffer strokes. The letters stand for:
| Letter | Risk factor | Points |
|---|---|---|
| C | Congestive heart failure | 1 |
| H | Hypertension | 1 |
| A₂ | Age ≥ 75 years | 2 |
| D | Diabetes mellitus | 1 |
| S₂ | Stroke / TIA / thromboembolism history | 2 |
| V | Vascular disease (CAD, PAD, aortic plaque) | 1 |
| A | Age 65–74 years | 1 |
| Sc | Sex category — female | 1 |
The maximum is 9 points. The higher the score, the higher the annual stroke risk without anticoagulation.
Annual stroke risk by score
Risk estimates are derived from the Swedish AF cohort study by Friberg et al. (Eur Heart J 2012, n = 90,490):
| Score | Annual risk | Recommendation |
|---|---|---|
| 0 | 0.2 % | No OAC |
| 1 | 0.6 % | Consider OAC |
| 2 | 2.2 % | OAC recommended |
| 3 | 3.2 % | OAC recommended |
| 4 | 4.8 % | OAC recommended |
| 5 | 7.2 % | OAC recommended |
| 6 | 9.7 % | OAC recommended |
| 7 | 11.2 % | OAC recommended |
| 8–9 | 10.8–12.2 % | OAC recommended |
Adequate oral anticoagulation (OAC) reduces stroke risk by about 64 % (Hart et al., Ann Intern Med 2007).
When is anticoagulation indicated?
The 2020 ESC guideline (Hindricks et al.) provides clear thresholds:
Men: from score ≥ 2
OAC is clearly recommended (Class I). First-line agents are direct oral anticoagulants (DOACs / NOACs) — apixaban, rivaroxaban, edoxaban, dabigatran. They outperform warfarin with similar efficacy and lower major bleeding risk.
Women: from score ≥ 3
Because women automatically receive +1 point for sex, the threshold is one higher. Female sex alone is not an indication for anticoagulation.
Score 1 (men) / 2 (women): individual decision
OAC may be considered — based on bleeding risk (HAS-BLED score), patient preference, and adherence. Shared decision-making with a cardiologist is recommended.
Bleeding risk: don't forget HAS-BLED
Before starting OAC, the HAS-BLED score should also be assessed to estimate bleeding risk. A high HAS-BLED (≥ 3) is not a contraindication but a flag to address modifiable factors:
- Treat hypertension to target
- Stop NSAIDs and aspirin where possible
- Reduce alcohol intake
- Avoid INR variability (with warfarin) or prefer DOACs
Calculate your CHA₂DS₂-VASc score now
8 risk factors, instant score, annual stroke risk and ESC anticoagulation guidance — anonymous and free.
Calculate now →How to lower your stroke risk
Beyond anticoagulation, most CHA₂DS₂-VASc components are modifiable:
- Blood pressure: target < 130/80 mmHg — every 10 mmHg drop halves stroke risk
- Diabetes: aim for HbA1c < 7.0 %, Mediterranean diet, exercise
- Cholesterol: LDL < 70 mg/dL in high-risk patients — statins as indicated
- Smoking cessation: halves stroke risk within 5 years
- Exercise: 150 min/week of moderate activity reduces risk by 27 %
- Weight: BMI < 30 — obesity drives both AF and stroke
Related calculators
Because stroke risk is closely tied to cardiovascular comorbidities, take a look at the blood pressure guide (hypertension is the strongest modifiable risk factor), the diabetes risk score (FINDRISC) and the cholesterol ratio as core markers of vascular health.
Bottom line
The CHA₂DS₂-VASc score is the international standard for stroke risk assessment in atrial fibrillation. From a score of 2 (men) or 3 (women), oral anticoagulation is recommended — it cuts stroke risk by roughly two thirds. Use our CHA₂DS₂-VASc calculator for self-assessment, and discuss any score ≥ 2 with your physician or cardiologist for optimal therapy.